[Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD

M Miravitlles, M Calle, J Molina, P Almagro… - Archivos de …, 2022 - Elsevier
Abstract The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since
then have undergone a series of updates incorporating new evidence on the diagnosis and …

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi… - … journal of chronic …, 2018 - Taylor & Francis
Recently, two “fixed triple” single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting β2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have …

Chronic respiratory infection in patients with chronic obstructive pulmonary disease: what is the role of antibiotics?

M Miravitlles, A Anzueto - International journal of molecular sciences, 2017 - mdpi.com
Chronic infections are associated with exacerbation in patients with chronic obstructive
pulmonary disease (COPD). The major objective of the management of these patients is the …

Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable

M Miravitlles, M Calle, J Molina, P Almagro… - Archivos de …, 2022 - Elsevier
Resumen La Guía Española de la Enfermedad Pulmonar Obstructiva Crónica (GesEPOC)
se publicó por primera vez en 2012 y desde entonces ha experimentado una serie de …

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment

Z Aisanov, S Avdeev, V Arkhipov… - … journal of chronic …, 2018 - Taylor & Francis
The high prevalence of COPD together with its high level of misdiagnosis and late diagnosis
dictate the necessity for the development and implementation of clinical practice guidelines …

Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study

M Calle Rubio, R Casamor… - International Journal of …, 2017 - Taylor & Francis
Background The Spanish Guidelines for COPD (GesEPOC) describe four clinical
phenotypes: non-exacerbator (NE), asthma-COPD overlap syndrome (ACO), frequent …

Clinical phenotypes of COPD and their impact on quality of life: A cross-sectional study

J Anandan, DP Dwivedi, V Govindaraj - Respiratory Medicine, 2023 - Elsevier
Abstract Background A Chronic Obstructive Pulmonary Disease (COPD) phenotype is a
single or group of disease characteristics that describe differences between individuals …

Validation of clinical control in COPD as a new tool for optimizing treatment

JJ Soler-Cataluña, M Marzo, P Catalán… - … Journal of Chronic …, 2018 - Taylor & Francis
Background It has recently been proposed that the concept of clinical control in COPD may
be useful for deciding treatment in COPD, but the original control criteria (OCC) were …

Predictive value of control of COPD for risk of exacerbations: an international, prospective study

M Miravitlles, P Sliwinski, CK Rhee, RW Costello… - …, 2020 - Wiley Online Library
Background and objective The concept of clinical control in COPD has been developed to
help in treatment decisions, but it requires validation in prospective studies. Methods This …

Accuracy of a new algorithm to identify asthma–COPD overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease

LP de Llano, BG Cosío, M Miravitlles, V Plaza… - Archivos de …, 2018 - Elsevier
Objectives We aimed to characterize the clinical, functional and inflammatory features of
patients diagnosed diagnosed with ACO according to a new algorithm and to compare them …